Virtus Biotech Clinical Trials ETF BBC
43.62 USD +0.81 (+1.89%)
At closeNov 4, 2026, 4:00 PM EST
44.00 +0.38 +0.87%
After hours · Nov 4, 4:00 PM ET
42.09 Day range 43.84
28.73 52-week range 56.18
- YTD
- +13.12%
- 1 year
- +43.53%
- Market cap
- 34.90M
- YTD return
- +13.12%
- 1-year return
- +43.53%
- Volume
- 206.88K
- Avg volume
- 28.11K
- Open
- 43.85
- Previous close
- 42.81
- Day's range
- 42.09 – 43.84
- 52-week range
- 28.73 – 56.18
5D -1.17 (-2.61%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 27.91
- 200-day average
- 27.48
About Virtus Biotech Clinical Trials ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
News
Trasteel Holding S.A. Completes Acquisition of the Remaining 40% Interest in BBC Alloys S.r.l. 
Venture Into High-Volatility Corners of the Market With These 3 ETFs 
Trump wins last-minute reprieve temporarily blocking BBC access to his business records 
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Sees Large Growth in Short Interest 
Biotech ETF (BBC) Touches Fresh 52-Week High 
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Sees Significant Increase in Short Interest 
Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026? 
Biotech ETF (BBC) Hits New 52-Week High 
Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears 
Best-Performing ETFs of Last Week: Healthcare Rules
Your note
Sign in to keep a note on BBC — it syncs with the Stock Master app.